Does low bioavailable testosterone modestly limit female muscle hypertrophy and androgen receptor signaling?

In female skeletal muscle physiology, the bioavailable fraction of testosterone plays a distinct, regulatory role in training-induced adaptations that cannot be predicted by total serum testosterone levels.

Androgen receptor signaling and cellular mechanisms

• Ligand-dependent translocation: Only bioavailable (free or albumin-bound) testosterone can bind cytosolic androgen receptors (AR). Low bioavailable testosterone restricts ligand-dependent AR dimerization, nuclear translocation, and subsequent genomic transcription of metabolic and contractile genes.
• High receptor sensitivity: Female (XX) muscle cells exhibit highly sensitive receptor dynamics, undergoing AR upregulation and nuclear translocation at lower testosterone thresholds than male (XY) cells.
• Ligand-independent pathways: Alternative pathways compensate during low-androgen states. For example, insulin-like growth factor-1 (IGF-1) can induce AR nuclear translocation and genomic signaling in skeletal muscle cells even in the absence of androgens.

Hypertrophic potential and adaptive pathways

• A modest physiological modulator: Bioavailable testosterone acts as a "fine-tuner" rather than an absolute barrier to muscle growth. While low levels modestly limit maximum hypertrophic potential, women consistently achieve significant muscle cross-sectional area and strength gains through structured resistance training.
• Estrogen-mediated support: Estrogen serves as a crucial parallel modulator of female muscle hypertrophy. In postmenopausal women experiencing age-related endocrine decline, estrogen supports training-induced adaptations, leading to greater increases in fat-free mass and muscle cross-sectional area when combined with resistance training.

Bottom line

• Low bioavailable testosterone modestly limits female hypertrophic potential by restricting classical ligand-dependent nuclear AR signaling. However, robust muscle adaptation remains highly viable through high cellular receptor sensitivity, progressive resistance training, and parallel anabolic pathways driven by estrogen and IGF-1.